The global Gene Therapy market is projected to grow from US$ 9197.1 million in 2024 to US$ 39700 million by 2030, at a Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period.

Gene Therapy Market

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Market Analysis and Insights: Global Gene Therapy Market

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.

In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Report Covers:

This report presents an overview of global market for Gene Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Gene Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Gene Therapy Market Report

Report Metric	Details
Report Name	Gene Therapy Market
Accounted market size in 2024	US$ 9197.1 million
Forecasted market size in 2030	US$ 39700 million
CAGR	27.6
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Viral Gene Therapy Non-Viral Gene Therapy
Segment by Application	Neurological Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Gene Therapy Market growing?

Ans: The Gene Therapy Market witnessing a CAGR of 27.6 during the forecast period 2024-2030.

What is the Gene Therapy Market size in 2030?

Ans: The Gene Therapy Market size in 2030 will be US$ 39700 million.

What is the market share of major companies in Gene Therapy Market?

Ans: Global top three manufacturers hold a share about 75%.

Who are the main players in the Gene Therapy Market report?

Ans: The main players in the Gene Therapy Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Therapy Market report?

Ans: The Applications covered in the Gene Therapy Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Therapy Market report?

Ans: The Types covered in the Gene Therapy Market report are Viral Gene Therapy, Non-Viral Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Viral Gene Therapy

1.2.3 Non-Viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy Market Perspective (2019-2030)

2.2 Global Gene Therapy Growth Trends by Region

2.2.1 Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Gene Therapy Market Dynamics

2.3.1 Gene Therapy Industry Trends

2.3.2 Gene Therapy Market Drivers

2.3.3 Gene Therapy Market Challenges

2.3.4 Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Gene Therapy by Players

3.1.1 Global Gene Therapy Revenue by Players (2019-2024)

3.1.2 Global Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Gene Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Gene Therapy Market Concentration Ratio

3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2023

3.5 Global Key Players of Gene Therapy Head office and Area Served

3.6 Global Key Players of Gene Therapy, Product and Application

3.7 Global Key Players of Gene Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Breakdown Data by Type

4.1 Global Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Gene Therapy Breakdown Data by Application

5.1 Global Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Therapy Market Size (2019-2030)

6.2 North America Gene Therapy Market Size by Type

6.2.1 North America Gene Therapy Market Size by Type (2019-2024)

6.2.2 North America Gene Therapy Market Size by Type (2025-2030)

6.2.3 North America Gene Therapy Market Share by Type (2019-2030)

6.3 North America Gene Therapy Market Size by Application

6.3.1 North America Gene Therapy Market Size by Application (2019-2024)

6.3.2 North America Gene Therapy Market Size by Application (2025-2030)

6.3.3 North America Gene Therapy Market Share by Application (2019-2030)

6.4 North America Gene Therapy Market Size by Country

6.4.1 North America Gene Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Gene Therapy Market Size by Country (2019-2024)

6.4.3 North America Gene Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Gene Therapy Market Size (2019-2030)

7.2 Europe Gene Therapy Market Size by Type

7.2.1 Europe Gene Therapy Market Size by Type (2019-2024)

7.2.2 Europe Gene Therapy Market Size by Type (2025-2030)

7.2.3 Europe Gene Therapy Market Share by Type (2019-2030)

7.3 Europe Gene Therapy Market Size by Application

7.3.1 Europe Gene Therapy Market Size by Application (2019-2024)

7.3.2 Europe Gene Therapy Market Size by Application (2025-2030)

7.3.3 Europe Gene Therapy Market Share by Application (2019-2030)

7.4 Europe Gene Therapy Market Size by Country

7.4.1 Europe Gene Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Gene Therapy Market Size by Country (2019-2024)

7.4.3 Europe Gene Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Gene Therapy Market Size (2019-2030)

8.2 China Gene Therapy Market Size by Type

8.2.1 China Gene Therapy Market Size by Type (2019-2024)

8.2.2 China Gene Therapy Market Size by Type (2025-2030)

8.2.3 China Gene Therapy Market Share by Type (2019-2030)

8.3 China Gene Therapy Market Size by Application

8.3.1 China Gene Therapy Market Size by Application (2019-2024)

8.3.2 China Gene Therapy Market Size by Application (2025-2030)

8.3.3 China Gene Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Gene Therapy Market Size (2019-2030)

9.2 Asia Gene Therapy Market Size by Type

9.2.1 Asia Gene Therapy Market Size by Type (2019-2024)

9.2.2 Asia Gene Therapy Market Size by Type (2025-2030)

9.2.3 Asia Gene Therapy Market Share by Type (2019-2030)

9.3 Asia Gene Therapy Market Size by Application

9.3.1 Asia Gene Therapy Market Size by Application (2019-2024)

9.3.2 Asia Gene Therapy Market Size by Application (2025-2030)

9.3.3 Asia Gene Therapy Market Share by Application (2019-2030)

9.4 Asia Gene Therapy Market Size by Region

9.4.1 Asia Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Gene Therapy Market Size by Region (2019-2024)

9.4.3 Asia Gene Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Gene Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Gene Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Gene Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Gene Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Gene Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Gene Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Gene Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Gene Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Gene Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Gene Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Gene Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Gene Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Gene Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Therapy Introduction

11.1.4 Biogen Revenue in Gene Therapy Business (2019-2024)

11.1.5 Biogen Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Therapy Introduction

11.2.4 Novartis Revenue in Gene Therapy Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Therapy Introduction

11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2019-2024)

11.3.5 Gilead Sciences Recent Developments

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Details

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Therapy Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2019-2024)

11.4.5 Sarepta Therapeutics Recent Developments

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2019-2024)

11.5.5 Alnylam Pharmaceuticals Recent Developments

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Therapy Introduction

11.6.4 Amgen Revenue in Gene Therapy Business (2019-2024)

11.6.5 Amgen Recent Developments

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Details

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Therapy Introduction

11.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2019-2024)

11.7.5 Spark Therapeutics Recent Developments

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Therapy Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2019-2024)

11.8.5 Akcea Therapeutics Recent Developments

11.9 bluebird bio

11.9.1 bluebird bio Company Details

11.9.2 bluebird bio Business Overview

11.9.3 bluebird bio Gene Therapy Introduction

11.9.4 bluebird bio Revenue in Gene Therapy Business (2019-2024)

11.9.5 bluebird bio Recent Developments

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Details

11.10.2 Sunway Biotech Business Overview

11.10.3 Sunway Biotech Gene Therapy Introduction

11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2019-2024)

11.10.5 Sunway Biotech Recent Developments

11.11 SIBIONO

11.11.1 SIBIONO Company Details

11.11.2 SIBIONO Business Overview

11.11.3 SIBIONO Gene Therapy Introduction

11.11.4 SIBIONO Revenue in Gene Therapy Business (2019-2024)

11.11.5 SIBIONO Recent Developments

11.12 AnGes

11.12.1 AnGes Company Details

11.12.2 AnGes Business Overview

11.12.3 AnGes Gene Therapy Introduction

11.12.4 AnGes Revenue in Gene Therapy Business (2019-2024)

11.12.5 AnGes Recent Developments

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Details

11.13.2 Orchard Therapeutics Business Overview

11.13.3 Orchard Therapeutics Gene Therapy Introduction

11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2019-2024)

11.13.5 Orchard Therapeutics Recent Developments

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Details

11.14.2 Human Stem Cells Institute Business Overview

11.14.3 Human Stem Cells Institute Gene Therapy Introduction

11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2019-2024)

11.14.5 Human Stem Cells Institute Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alnylam Pharmaceuticals

Human Stem Cells Institute

List of Tables

Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Viral Gene Therapy

Table 3. Key Players of Non-Viral Gene Therapy

Table 4. Global Gene Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Gene Therapy Market Share by Region (2019-2024)

Table 8. Global Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Gene Therapy Market Share by Region (2025-2030)

Table 10. Gene Therapy Market Trends

Table 11. Gene Therapy Market Drivers

Table 12. Gene Therapy Market Challenges

Table 13. Gene Therapy Market Restraints

Table 14. Global Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Gene Therapy Revenue Share by Players (2019-2024)

Table 16. Global Top Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)

Table 17. Global Gene Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Gene Therapy, Headquarters and Area Served

Table 20. Global Key Players of Gene Therapy, Product and Application

Table 21. Global Key Players of Gene Therapy, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Gene Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Gene Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Gene Therapy Revenue Share by Application (2019-2024)

Table 29. Global Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Gene Therapy Revenue Share by Application (2025-2030)

Table 31. North America Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Gene Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Gene Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Gene Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Gene Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Gene Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Gene Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Gene Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Gene Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Gene Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Gene Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 63. Biogen Company Details

Table 64. Biogen Business Overview

Table 65. Biogen Gene Therapy Product

Table 66. Biogen Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 67. Biogen Recent Developments

Table 68. Novartis Company Details

Table 69. Novartis Business Overview

Table 70. Novartis Gene Therapy Product

Table 71. Novartis Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 72. Novartis Recent Developments

Table 73. Gilead Sciences Company Details

Table 74. Gilead Sciences Business Overview

Table 75. Gilead Sciences Gene Therapy Product

Table 76. Gilead Sciences Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 77. Gilead Sciences Recent Developments

Table 78. Sarepta Therapeutics Company Details

Table 79. Sarepta Therapeutics Business Overview

Table 80. Sarepta Therapeutics Gene Therapy Product

Table 81. Sarepta Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 82. Sarepta Therapeutics Recent Developments

Table 83. Alnylam Pharmaceuticals Company Details

Table 84. Alnylam Pharmaceuticals Business Overview

Table 85. Alnylam Pharmaceuticals Gene Therapy Product

Table 86. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 87. Alnylam Pharmaceuticals Recent Developments

Table 88. Amgen Company Details

Table 89. Amgen Business Overview

Table 90. Amgen Gene Therapy Product

Table 91. Amgen Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 92. Amgen Recent Developments

Table 93. Spark Therapeutics Company Details

Table 94. Spark Therapeutics Business Overview

Table 95. Spark Therapeutics Gene Therapy Product

Table 96. Spark Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 97. Spark Therapeutics Recent Developments

Table 98. Akcea Therapeutics Company Details

Table 99. Akcea Therapeutics Business Overview

Table 100. Akcea Therapeutics Gene Therapy Product

Table 101. Akcea Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 102. Akcea Therapeutics Recent Developments

Table 103. bluebird bio Company Details

Table 104. bluebird bio Business Overview

Table 105. bluebird bio Gene Therapy Product

Table 106. bluebird bio Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 107. bluebird bio Recent Developments

Table 108. Sunway Biotech Company Details

Table 109. Sunway Biotech Business Overview

Table 110. Sunway Biotech Gene Therapy Product

Table 111. Sunway Biotech Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 112. Sunway Biotech Recent Developments

Table 113. SIBIONO Company Details

Table 114. SIBIONO Business Overview

Table 115. SIBIONO Gene Therapy Product

Table 116. SIBIONO Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 117. SIBIONO Recent Developments

Table 118. AnGes Company Details

Table 119. AnGes Business Overview

Table 120. AnGes Gene Therapy Product

Table 121. AnGes Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 122. AnGes Recent Developments

Table 123. Orchard Therapeutics Company Details

Table 124. Orchard Therapeutics Business Overview

Table 125. Orchard Therapeutics Gene Therapy Product

Table 126. Orchard Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 127. Orchard Therapeutics Recent Developments

Table 128. Human Stem Cells Institute Company Details

Table 129. Human Stem Cells Institute Business Overview

Table 130. Human Stem Cells Institute Gene Therapy Product

Table 131. Human Stem Cells Institute Revenue in Gene Therapy Business (2019-2024) & (US$ Million)

Table 132. Human Stem Cells Institute Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Gene Therapy Market Share by Type: 2023 VS 2030

Figure 3. Viral Gene Therapy Features

Figure 4. Non-Viral Gene Therapy Features

Figure 5. Global Gene Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Gene Therapy Market Share by Application: 2023 VS 2030

Figure 7. Neurological Diseases Case Studies

Figure 8. Cancer Case Studies

Figure 9. Other Case Studies

Figure 10. Gene Therapy Report Years Considered

Figure 11. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Gene Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Gene Therapy Market Share by Players in 2023

Figure 15. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2023

Figure 17. North America Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Gene Therapy Market Share by Type (2019-2030)

Figure 19. North America Gene Therapy Market Share by Application (2019-2030)

Figure 20. North America Gene Therapy Market Share by Country (2019-2030)

Figure 21. United States Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Gene Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Gene Therapy Market Share by Type (2019-2030)

Figure 25. Europe Gene Therapy Market Share by Application (2019-2030)

Figure 26. Europe Gene Therapy Market Share by Country (2019-2030)

Figure 27. Germany Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Gene Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Gene Therapy Market Share by Type (2019-2030)

Figure 35. China Gene Therapy Market Share by Application (2019-2030)

Figure 36. Asia Gene Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Gene Therapy Market Share by Type (2019-2030)

Figure 38. Asia Gene Therapy Market Share by Application (2019-2030)

Figure 39. Asia Gene Therapy Market Share by Region (2019-2030)

Figure 40. Japan Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Gene Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Gene Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Gene Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Gene Therapy Market Share by Country (2019-2030)

Figure 50. Brazil Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Biogen Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 57. Novartis Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 58. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 61. Amgen Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 62. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 63. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 64. bluebird bio Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 65. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 66. SIBIONO Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 67. AnGes Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 68. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 69. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions